Business - Briefly   

Ranbaxy recalls Nitrofurantoin capsules

MUMBAI: Ranbaxy Laboratories on Saturday said it had recalled all lots of Nitrofurantoin capsules, used in the treatment of infections. Ranbaxy Pharmaceutical Inc (RPI), a wholly-owned U.S. subsidiary of the company, had recalled all lots of Nitrofurantoin (Monohydrate/Macrocrystals) capsules, United States Pharmacopeia (USP) 100 mg, available in the market there, Ranbaxy said in a statement.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

CII projects 6.1-6.5% GDP growth this fiscal
Vizag Port to expand cargo handling capacity
SBI cuts deposit rates by 25 bps
Gulf Air to cancel Jet lease deal
Bullion Rates
Taj GVK Hotels net at Rs. 53 crore
Elgi Equipments declares Rs. 1.30 per share
Asia Fruit Logistica 2009
IBM introduces Xeon processor-based servers
IDS Software solution for hospitality sector
Marginal rise in Titan net profit
Ranbaxy recalls Nitrofurantoin capsules

Copyright © 2009, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu